splash

Oxford Capital Partners News

02 July 2009: Scancell Scancell has signs licensing agreement with Merck Serono
18 June 2009: Microbial Solutions Microbial Solutions achieves ISO 9001 accreditation
18 June 2009: Rostima Rostima Tracking Productivity - Keeping the Skills
18 May 2009: Oxford BioTherapeutics Oxford BioTherapeutics in £244m deal with Glaxo
14 May 2009: Helveta Helveta helps Liberia to barcode trees to log profits
13 May 2009: Exosect Exosect Obtains an Emergency Approval for the Control of Light Brown Apple Moth
12 May 2009: Exosect New Green Exosect Technology Protects and Maximises Yield For Rice Growers In India
11 May 2009: OrthoMimetics New tissue scaffold regrows cartilage and bone
23 April 2009: Sphere Sphere Medical achieves CE Marking for BGE analyser
14 April 2009: Veryan Veryan Medical completes latest £2.5m funding round
09 April 2009: Helveta Helveta feature in Sunday Times
19 March 2009: Glide Pharma Lipoxen enters into agreement with Glide Pharma
19 March 2009: Arieso Limited European operator to enhance customer experience & reduce costs with ariesoGEO
06 March 2009: OrthoMimetics Orthomimetics treats first patient with implant for regenerative repair
04 March 2009: Oxitec Oxitec Present at Davos World Economic Forum
04 March 2009: Hardide Hardide announces success in coating of titanium
18 February 2009: Concurrent Thinking Concurrent Thinking announces cost saving measures for clusters
13 February 2009: Exosect Oxford Capital Partners, Entrepreneurs Fund and WHEB Ventures close a further £2m investment in Exosect
07 February 2009: Exosect Exosect gains prominent European partner after registration with Intrachem Bio, Italy is granted
06 February 2009: Microbial Solutions Microbial Solutions completes Successful Trial of Environmental toxin-eating Technology
14 January 2009: OrthoMimetics Orthomimetics Secures CE Mark Approval for Chondromimetic
13 January 2009: Inetec Inetec leads £30bn energy revolution

Related Pages

Request Information

Click here to request information from Oxford Capital Partners